• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

聚乙烯亚胺的结构修饰以控制无定形固体分散体的载药和释放特性

Structural Modifications of Polyethylenimine to Control Drug Loading and Release Characteristics of Amorphous Solid Dispersions.

作者信息

Kelsall Kristen N, Foroughi Leila M, Frank Derek S, Schenck Luke, LaBuda Anthony, Matzger Adam J

机构信息

Department of Chemistry, University of Michigan, Ann Arbor, Michigan 48109, United States.

Macromolecular Science and Engineering Program, University of Michigan, Ann Arbor, Michigan 48109, United States.

出版信息

Mol Pharm. 2023 Mar 6;20(3):1779-1787. doi: 10.1021/acs.molpharmaceut.2c00970. Epub 2023 Jan 31.

DOI:10.1021/acs.molpharmaceut.2c00970
PMID:36719910
Abstract

Crystalline drugs with low solubility have the potential to benefit from delivery in the amorphous form. The polymers used in amorphous solid dispersions (ASDs) influence their maximum drug loading, solubility, dissolution rate, and physical stability. Herein, the influence of hydrophobicity of crosslinked polyethylenimine (PEI) is investigated for the delivery of the BCS class II nonsteroidal anti-inflammatory drug flufenamic acid (ffa). Several synthetic variables for crosslinking PEI with terephthaloyl chloride were manipulated: solvent, crosslinking density, reactant concentration, solution viscosity, reaction temperature, and molecular weight of the hyperbranched polymer. Benzoyl chloride was employed to cap amine groups to increase the hydrophobicity of the crosslinked materials. Amorphous deprotonated ffa was present in all ASDs; however, the increased hydrophobicity and reduced basicity from benzoyl functionalization led to a combination of amorphous deprotonated ffa and amorphous neutral ffa in the materials at high drug loadings (50 and 60 wt %). All ASDs demonstrated enhanced drug delivery in acidic media compared to crystalline ffa. Physical stability testing showed no evidence of crystallization after 29 weeks under various relative humidity conditions. These findings motivate the broadening of polymer classes employed in ASD formation to include polymers with very high functional group concentrations to enable loadings not readily achieved with existing polymers.

摘要

低溶解度的结晶药物有可能从无定形形式的给药中获益。用于无定形固体分散体(ASD)的聚合物会影响其最大载药量、溶解度、溶解速率和物理稳定性。在此,研究了交联聚乙烯亚胺(PEI)的疏水性对BCS II类非甾体抗炎药氟芬那酸(ffa)给药的影响。对用对苯二甲酰氯交联PEI的几个合成变量进行了调控:溶剂、交联密度、反应物浓度、溶液粘度、反应温度和超支化聚合物的分子量。使用苯甲酰氯封端胺基以增加交联材料的疏水性。所有ASD中均存在无定形去质子化ffa;然而,苯甲酰官能化导致的疏水性增加和碱性降低,在高载药量(50%和60%重量)下,材料中出现了无定形去质子化ffa和无定形中性ffa的组合。与结晶ffa相比,所有ASD在酸性介质中均表现出增强的药物递送。物理稳定性测试表明,在各种相对湿度条件下29周后没有结晶迹象。这些发现促使扩大用于形成ASD的聚合物类别,以包括具有非常高官能团浓度的聚合物,从而实现现有聚合物难以达到的载药量。

相似文献

1
Structural Modifications of Polyethylenimine to Control Drug Loading and Release Characteristics of Amorphous Solid Dispersions.聚乙烯亚胺的结构修饰以控制无定形固体分散体的载药和释放特性
Mol Pharm. 2023 Mar 6;20(3):1779-1787. doi: 10.1021/acs.molpharmaceut.2c00970. Epub 2023 Jan 31.
2
Effect of Polymer Hydrophobicity on the Stability of Amorphous Solid Dispersions and Supersaturated Solutions of a Hydrophobic Pharmaceutical.聚合物疏水性对疏水性药物无定形固体分散体和过饱和溶液稳定性的影响。
Mol Pharm. 2019 Feb 4;16(2):682-688. doi: 10.1021/acs.molpharmaceut.8b00972. Epub 2019 Jan 15.
3
Balancing Solid-State Stability and Dissolution Performance of Lumefantrine Amorphous Solid Dispersions: The Role of Polymer Choice and Drug-Polymer Interactions.平衡稳定性和溶解性能的固态无定形固体分散体:聚合物选择和药物-聚合物相互作用的作用。
Mol Pharm. 2022 Feb 7;19(2):392-413. doi: 10.1021/acs.molpharmaceut.1c00481. Epub 2021 Sep 8.
4
Enhanced kinetic solubility profiles of indomethacin amorphous solid dispersions in poly(2-hydroxyethyl methacrylate) hydrogels.聚(2-羟乙基甲基丙烯酸酯)水凝胶中吲哚美辛无定形固体分散体的增强动力学溶解度谱。
Eur J Pharm Biopharm. 2012 May;81(1):149-58. doi: 10.1016/j.ejpb.2011.12.016. Epub 2012 Jan 2.
5
Congruent Release of Drug and Polymer from Amorphous Solid Dispersions: Insights into the Role of Drug-Polymer Hydrogen Bonding, Surface Crystallization, and Glass Transition.无定形固体分散体中药物和聚合物的一致释放:对药物-聚合物氢键、表面结晶和玻璃化转变作用的深入了解。
Mol Pharm. 2020 Apr 6;17(4):1261-1275. doi: 10.1021/acs.molpharmaceut.9b01272. Epub 2020 Mar 17.
6
Patterns of drug release as a function of drug loading from amorphous solid dispersions: A comparison of five different polymers.作为无定形固体分散体载药量函数的药物释放模式:五种不同聚合物的比较
Eur J Pharm Sci. 2020 Dec 1;155:105514. doi: 10.1016/j.ejps.2020.105514. Epub 2020 Aug 15.
7
Insights into the Dissolution Mechanism of Ritonavir-Copovidone Amorphous Solid Dispersions: Importance of Congruent Release for Enhanced Performance.利托那韦-共聚维酮无定形固体分散体的溶解机制研究:一致释放对于增强性能的重要性。
Mol Pharm. 2019 Mar 4;16(3):1327-1339. doi: 10.1021/acs.molpharmaceut.8b01261. Epub 2019 Feb 5.
8
Probing the Interplay between Amorphous Solid Dispersion Stability and Polymer Functionality.探究无定形固体分散体稳定性与聚合物功能之间的相互作用。
Mol Pharm. 2018 Jul 2;15(7):2714-2720. doi: 10.1021/acs.molpharmaceut.8b00219. Epub 2018 Jun 20.
9
Monitoring Polymorphic Phase Transitions in Flufenamic Acid Amorphous Solid Dispersions Using Hyphenated X-ray Diffraction-Differential Scanning Calorimetry.使用 X 射线衍射-差示扫描量热法联用技术监测氟芬那酸无定形固体分散体中的多晶型相变。
Mol Pharm. 2022 May 2;19(5):1477-1487. doi: 10.1021/acs.molpharmaceut.2c00016. Epub 2022 Mar 29.
10
Moisture-Induced Amorphous Phase Separation of Amorphous Solid Dispersions: Molecular Mechanism, Microstructure, and Its Impact on Dissolution Performance.无定形固体分散体的水分诱导无定形相分离:分子机制、微观结构及其对溶解性能的影响。
J Pharm Sci. 2018 Jan;107(1):317-326. doi: 10.1016/j.xphs.2017.10.028. Epub 2017 Oct 26.

引用本文的文献

1
The Implications of Drug-Polymer Interactions on the Physical Stability of Amorphous Solid Dispersions.药物-聚合物相互作用对无定形固体分散体物理稳定性的影响。
Pharm Res. 2023 Dec;40(12):2963-2981. doi: 10.1007/s11095-023-03547-4. Epub 2023 Jun 30.